These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. A controlled trial of alternate day prednisolone as a maintenance treatment for ulcerative colitis in remission. Powell-Tuck J; Bown RL; Chambers TJ; Lennard-Jones JE Digestion; 1981; 22(5):263-70. PubMed ID: 7030837 [TBL] [Abstract][Full Text] [Related]
43. Prednisolone absorption in acute colitis. Elliott PR; Powell-Tuck J; Gillespie PE; Laidlow JM; Lennard-Jones JE; English J; Chakraborty J; Marks V Gut; 1980 Jan; 21(1):49-51. PubMed ID: 7364320 [TBL] [Abstract][Full Text] [Related]
44. Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis. Campieri M; Gionchetti P; Belluzzi A; Brignola C; Tampieri M; Iannone P; Miglioli M; Barbara L Gut; 1991 Aug; 32(8):929-31. PubMed ID: 1885075 [TBL] [Abstract][Full Text] [Related]
45. Retrograde distribution of a new 5-aminosalicylic acid enema in patients with ulcerative colitis. Almer S; Ekberg S; Ström M Gastroenterol Clin Biol; 1992; 16(6-7):564-8. PubMed ID: 1526419 [TBL] [Abstract][Full Text] [Related]
47. A steroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis. Danielsson A; Löfberg R; Persson T; Salde L; Schiöler R; Suhr O; Willén R Scand J Gastroenterol; 1992; 27(1):9-12. PubMed ID: 1736348 [TBL] [Abstract][Full Text] [Related]
48. Enema volume as an important factor in successful topical corticosteroid treatment of colitis. Swarbrick ET; Loose H; Lennard-Jones JE Proc R Soc Med; 1974 Aug; 67(8):753-4. PubMed ID: 4417491 [No Abstract] [Full Text] [Related]
49. Treatment of ulcerative colitis by the direct administration of an antifibrinolytic agent as an enema. Kondo M; Hotta T; Takemura S; Yoshikawa T; Fukumoto K Hepatogastroenterology; 1981 Oct; 28(5):270-3. PubMed ID: 7047340 [TBL] [Abstract][Full Text] [Related]
50. Neutrophil and eosinophil granule proteins as markers of response to local prednisolone treatment in distal ulcerative colitis and proctitis. Sangfelt P; Carlson M; Thörn M; Lööf L; Raab Y Am J Gastroenterol; 2001 Apr; 96(4):1085-90. PubMed ID: 11316151 [TBL] [Abstract][Full Text] [Related]
51. Treatment of ulcerative colitis with hydrocortisone alcohol retention enemas: a topical and systemic anti-inflammatory agent. II. Sherman LF; Tenner RJ; Schottler JL Dis Colon Rectum; 1967; 10(1):43-52. PubMed ID: 6018350 [No Abstract] [Full Text] [Related]
52. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group. Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559 [TBL] [Abstract][Full Text] [Related]
53. Collagenous colitis: possible response to sulfasalazine and local steroid therapy. Farah DA; Mills PR; Lee FD; McLay A; Russell RI Gastroenterology; 1985 Mar; 88(3):792-7. PubMed ID: 2857147 [TBL] [Abstract][Full Text] [Related]
54. Refractory distal ulcerative colitis responsive to 5-aminosalicylate enemas. Barber GB; Lee DE; Antonioli DA; Peppercorn MA Am J Gastroenterol; 1985 Aug; 80(8):612-4. PubMed ID: 2862789 [TBL] [Abstract][Full Text] [Related]
55. Colonic irritability due to a mercurial bacteriostat in retention enemata. MATTS SG; BARON JH; CONNELL AM; LENNARD-JONES JE Gut; 1962 Mar; 3(1):91-2. PubMed ID: 14471442 [TBL] [Abstract][Full Text] [Related]
56. The proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids. Egesten A; Eliasson M; Olin AI; Erjefält JS; Bjartell A; Sangfelt P; Carlson M Int J Colorectal Dis; 2007 Dec; 22(12):1421-7. PubMed ID: 17703315 [TBL] [Abstract][Full Text] [Related]
57. Difficulties in Performing Mesalazine Enemas and Factors Related to Discontinuation Among Patients With Ulcerative Colitis. Kawakami A; Tanaka M; Ochiai R; Naganuma M; Kunisaki R; Kazuma K Gastroenterol Nurs; 2017; 40(2):101-108. PubMed ID: 27490278 [TBL] [Abstract][Full Text] [Related]
58. A successful case of intraarterial prednisolone injection therapy in severe ulcerative colitis unresponsive to an intensive intravenous regimen. Ishii N; Chiba M; Suzuki T; Iizuka M; Masamune O; Kubo N Gastroenterol Jpn; 1993 Oct; 28(5):725-9. PubMed ID: 8224625 [TBL] [Abstract][Full Text] [Related]